A Phase 3 Study of Etelcalceide in Pediatric Subjects With Secondary Hyperparathyroidism and CKD on Hemodialysis.

Conditions:   Secondary Hyperparathyroidism;   Chronic Kidney Disease Intervention:   Drug: Etelcalcetide Sponsor:   Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials